Form 4 for KPRX KIORA PHARMACEUTICALS INC
Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-29 · accession 0001372514-23-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-03 | 2023-09-29 | KPRX | Strem Brian M. | Pres, CEO, Dir | A - Grant | $0.00 | +75.0K | 103.8K | +261% | $0 |
| D | 2023-10-03 | 2023-09-29 | KPRX | Strem Brian M. | Pres, CEO, Dir | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-29 | A | A | 75,000 | $0.00 | 103,783 | D | — | — | (F1) Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-09-29 | A | A | 150,000 | $0.00 | 150,000 | D | $0.57 · 2023-09-29 to 2033-09-29 | 150,000 Common Stock | (F2) The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. |